medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2015-9-26-33medsovet-241Research ArticleИнфекции в акушерстве и гинекологииInfections in obstetrics and gynecologyБактериальный вагиноз: новые перспективы в леченииBacterial vaginosis: new treatment prospectХрянинА. А.KhryaninA. A.noemail@neicon.ruРешетниковО. В.ReshetnikovO. V.noemail@neicon.ruНовосибирский государственный медицинский университет Минздрава РоссииРоссияNovosibirsk State Medical University, Ministry of Health of Russia, NovosibirskRussian FederationНаучно-исследовательский институт терапии и профилактической медицины, НовосибирскРоссияResearch Institute of Therapy and Preventive Medicine, NovosibirskRussian Federation201530122015092633Copyright © Хрянин А.А., Решетников О.В., 20152015Хрянин А.А., Решетников О.В.Khryanin A.A., Reshetnikov O.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/241

Бактериальный вагиноз - это инфекционный невоспалительный синдром, характеризующийся заменой обычной микрофлоры (преимущественно лактобактерий) на полимикробные ассоциации анаэробов и Gardnerella vaginalis. В последние годы использование методов молекулярной биологии показало, что существует гораздо большее разнообразие микроорганизмов, ассоциированных с бактериальным вагинозом, чем считалось ранее. Клиндамицин зарекомендовал себя как эффективный и безопасный препарат в лечении бактериального вагиноза в современных условиях.

Bacterial vaginosis is an infectious non-inflammatory syndrome characterized by replacement of normal microflora (mainly lactobacilli) with polymicrobial associations of anaerobes and Gardnerella vaginalis. Recently, the molecular biology techniques showed that there is a much greater variety of microorganisms associated with bacterial vaginosis than previously thought. Clindamycin has demonstrated its efficacy and safety in the treatment of bacterial vaginosis today.

бактериальный вагинозGardnerella vaginalisлактобактерииклиндамицинлечениеbacterial vaginosislactobacilliclindamycintreatmentReferencesAnderson MR, KLink K, Cohrssen A. Evaluation of vaginal complaints. JAMA, 2004, 291:11:1368-1379.Anderson MR, KLink K, Cohrssen A. Evaluation of vaginal complaints. JAMA, 2004, 291:11:1368-1379.Mitchell H. Vaginal discharge - causes, diagnosis, and treatment. BMJ, 2004, 328:7451:1306-1308.Mitchell H. Vaginal discharge - causes, diagnosis, and treatment. BMJ, 2004, 328:7451:1306-1308.Хрянин А.А., Решетников О.В. Бактериальный вагиноз: новые представления о микробном биосоциуме и возможности лечения. Медицинский совет, 2014, 17: 128-133.Хрянин А.А., Решетников О.В. Бактериальный вагиноз: новые представления о микробном биосоциуме и возможности лечения. Медицинский совет, 2014, 17: 128-133.Verstraelen H, Swidsinski A. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment. Curr Opin Infect Dis, 2013, 26: 86-89.Verstraelen H, Swidsinski A. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment. Curr Opin Infect Dis, 2013, 26: 86-89.Gillet E, Meys JFA, Verstraelen H et al. Association between bacterial vaginosis and cervical intraepithelial neoplasia: Systematic review and meta-analysis. Plos One, 2012, 7, Issue 10 e45201.Gillet E, Meys JFA, Verstraelen H et al. Association between bacterial vaginosis and cervical intraepithelial neoplasia: Systematic review and meta-analysis. Plos One, 2012, 7, Issue 10 e45201.Lamont RF, Sobel JD, Akins RA et al. The vaginal microbiome: New information about genital tract flora using molecular based techniques. BJOG, 2011, 118(5): 533-549.Lamont RF, Sobel JD, Akins RA et al. The vaginal microbiome: New information about genital tract flora using molecular based techniques. BJOG, 2011, 118(5): 533-549.Muzny CA, Sunesara IR, Griswold ME et al. Association between BVAB1 and high Nugent scores among women with bacterial vaginosis. Diagn Microbiol Infect Dis., 2014 December, 80(4): 321-323.Muzny CA, Sunesara IR, Griswold ME et al. Association between BVAB1 and high Nugent scores among women with bacterial vaginosis. Diagn Microbiol Infect Dis., 2014 December, 80(4): 321-323.Di Giulio DB, Callahan BJ, McMurdie PJ et al. Temporal and spatial variation of the human microbiota during pregnancy Proceedings of the National Academy of Sciences 2015/ www.pnas.org/cgi/doi/10.1073/ pnas.1502875112.Di Giulio DB, Callahan BJ, McMurdie PJ et al. Temporal and spatial variation of the human microbiota during pregnancy Proceedings of the National Academy of Sciences 2015/ www.pnas.org/cgi/doi/10.1073/ pnas.1502875112.Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med, 1983, 74(1): 14-22.Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med, 1983, 74(1): 14-22.Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol, 1991, 29(2): 297-301.Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol, 1991, 29(2): 297-301.Mohammadzadeh F, Dolatian M, Jorjani M, Alavi Majd H. Diagnostic value of Amsel's clinical criteria for diagnosis of bacterial vaginosis. Glob J Health Sci., 2014 Oct 29, 7(3): 8-14.Mohammadzadeh F, Dolatian M, Jorjani M, Alavi Majd H. Diagnostic value of Amsel's clinical criteria for diagnosis of bacterial vaginosis. Glob J Health Sci., 2014 Oct 29, 7(3): 8-14.Workowski KA. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recommend Rep 2010; 59:61-63.Workowski KA. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recommend Rep 2010; 59:61-63.Лебеденко Е.Ю. На грани материнских потерь («near miss»). Под ред. В.Е. Радзинского. М., 2011.Лебеденко Е.Ю. На грани материнских потерь («near miss»). Под ред. В.Е. Радзинского. М., 2011.Vouga M, Greub G, Prodhom G, et al. Treatment of genital mycoplasma in colonized pregnant women in late pregnancy is associated with a lower rate of premature labour and neonatal complications. Clin Microbiol Infect, 2014 Oct, 20(10): 1074-9.Vouga M, Greub G, Prodhom G, et al. Treatment of genital mycoplasma in colonized pregnant women in late pregnancy is associated with a lower rate of premature labour and neonatal complications. Clin Microbiol Infect, 2014 Oct, 20(10): 1074-9.Donders GG, Zodzika J, Rezeberga D. Treatment of bacterial vaginosis: what we have and what we miss. Expert Opin Pharmacother, 2014 Apr, 15(5): 645-57.Donders GG, Zodzika J, Rezeberga D. Treatment of bacterial vaginosis: what we have and what we miss. Expert Opin Pharmacother, 2014 Apr, 15(5): 645-57.Fischbach F, Petersen EE, Weissenbacher ER, et al. Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol, 1993 Sep, 82(3): 405-10.Fischbach F, Petersen EE, Weissenbacher ER, et al. Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol, 1993 Sep, 82(3): 405-10.Han C, Wu W, Fan A, Wang Y, Zhang H, Chu Z, Wang C, Xue F. Diagnostic and therapeutic advancements for aerobic vaginitis. Arch Gynecol Obstet, 2015 Feb, 291(2): 251-7Han C, Wu W, Fan A, Wang Y, Zhang H, Chu Z, Wang C, Xue F. Diagnostic and therapeutic advancements for aerobic vaginitis. Arch Gynecol Obstet, 2015 Feb, 291(2): 251-7

The authors declare that there are no conflicts of interest present.